The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their ...

PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced ...

The pivotal clinical phase 3 trial for the olanzapine Long-Acting Injectable (LAI) in schizophrenia (SOLARIS) has been completed, following the final visit of the last patient in the 48 weeks open ...

Vetigenics is seeing encouraging results of a completed study for an antibody aimed at treating oral melanoma in dogs, used ...

David Klonoff, MD, Clinical Professor of Medicine at University of California, San Francisco and Editor-in-Chief of the Journal of Diabetes Science and Technology, said "The successful completion of .

I can tell you that VDPHL01 has a unique profile unlike current FDA-approved treatments, which are associated with cardiac ...

The conundrum of missing data vs. inter-rater variability.

"The completion of construction of this impressive facility ... such as the recent launches of clinical trials for infectious diseases vaccines." PharmiWeb.com is Europe's leading industry-sponsored ...

The Safety Review Committee monitoring the clinical trial unanimously approved opening of the third cohort based on its review of Cohort 1 and 2 safety and pharmacokinetic (PK) data and is monitoring ...

Glucotrack, Inc. has announced the successful completion of its first human ... The promise of further development and clinical trials for this innovative system was echoed by Dr. David Klonoff ...

today announced the first Cohort B patient in the ACHIEVE Phase 2B UK clinical trial, evaluating TCB008 in Acute Myeloid Leukemia, has completed the full dosing regiment. The ACHIEVE trial is an ...